RX&D Logo

Innovative Medicines Canada
Code of Ethical Practices

Table of Contents Favourites News Resources Events

  • Language: EN
    • EN EN
    • FR FR
  • Introduction
  • 1Guiding Principles
  • 2Privacy of Patient Information
  • 3Transparency
  • 4Members’ Employees
  • 5Scientific Exchanges
  • 6Business Meetings and Discussions
  • 7Retaining the Services of a Stakeholder
  • 8Consultant Meetings
  • 9Learning Programs for Health Care Professionals
  • 10Conferences and Congresses
  • 11Displays
  • 12Provision of Funding
  • 13Collaborations and Partnerships
  • 14Loan of Medical Equipment
  • 15Patient Support Programs and Medical Practice Activities
  • 16Service-Oriented Items
  • 17Clinical Evaluation Packages (“Samples”)
  • 18Market Research
  • 19Post Registration Clinical Studies
  • 20Enforcement
  • ANNEX A - Innovative Medicines Canada Guidelines for Transparency in Stakeholder Funding

My Favourites

FavoriteLoadingClear favorites

News

  • The Complex Journey of a Vaccine
  • Innovative Medicines Canada welcomes Prime Minister Trudeau’s plan to mobilize science to fight COVID-19
  • Statement on Canada’s Drug Supply
  • Canada’s Research-Based Pharmaceutical Companies and the Fight Against Covid-19
  • Quebec Budget: Innovative Medicines Canada welcomes investments in the life sciences, innovation and health sectors

Resources

  • QUESTIONS & ANSWERS

  • NOTE FOR GUIDANCE ON PATIENT SUPPORT PROGRAMS AND MEDICAL PRACTICE ACTIVITIES

  • NOTE FOR GUIDANCE ON EVENTS AND MEETINGS ORGANIZED OR SPONSORED BY COMPANIES

  • NOTE FOR GUIDANCE ON RETAINING THE SERVICES OF STAKEHOLDERS

Events


Sorry, can not connect to the events feed.
  • No items
2020
Code d'éthiqueAppuyez ici pour Francais
Code of EthicsClick Here for English
X
Questions about this App? Please send us an email at
code@imc-mnc.ca.